Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can money skills and peer support help teens beat HIV? new study tests four tools together.

NCT ID NCT05600621

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests four different support tools—financial literacy training, matched savings accounts, a cartoon-based adherence guide, and role models with HIV—to see which combination best helps youth aged 11-17 in Uganda stay on their HIV medication and keep the virus undetectable. About 576 adolescents from 48 clinics will be assigned to different combinations of these tools and followed for three years. The goal is to find the most effective and affordable way to improve long-term viral suppression.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Financial literacy training, matched savings accounts, adherence cartoon, and role model engagement
What this could lead to
If successful, this could identify a cost-effective combination of behavioral and economic supports to help youth with HIV stay on treatment and achieve long-term viral suppression.
What could go wrong
This is a behavioral intervention study, not a drug trial, so results may vary by setting. The 3-year follow-up is long, but adherence may still drop after the study ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

576 people

The number who actually took part.

Started

Jun 2023

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adolescent: * living with HIV (confirmed by medical report and aware of status) * living within a family * being 11-17 years of age (at enrollment) * prescribed ART * enrolled in ART care at one of the 48 health clinics in the study districts. Health clinics would be eligible if they: * have existing procedures tailored to adolescent adherence (including adolescent-specific clinic days and peer counselling) * Accredited by the Uganda Ministry of Health as a provider of ART within the study districts. Exclusion Criteria: * Includes an inability to understand study procedures and participant rights as assessed during informed consent/assent process with the adolescent or parent. * If the adolescent or adult caregiver presents with emergency needs (e.g., hospitalization), needed care will be secured, rather than study participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • International Center for Child Health and Development

    Masaka, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.